Cited by 1,957Cannabis and Cannabinoid ResearchNeuroscience and Neuropharmacology ResearchReceptor Mechanisms and Signaling

The DOI matches its Crossref record; 151 of the 152 references it cites were found in a registry or an index.

The molecular logic of endocannabinoid signalling

Open access

Piomelli, Daniele·2003·Nature Reviews Neuroscience

DOI 10.1038/nrn1247

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1038/nrn1247

Cites

151 of 151 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Unresponsiveness to Cannabinoids and Reduced Addictive Effects of Opiates in CB 1 Receptor Knockout Mice
Ledent, C. A., Valverde, O., Cossu, G., Petitet, F., Aubert, J.-F., Beslot, F., Böhme, G. A., Impérato, A., Pedrazzini, T., Roques, B. P., et al. (1999) · Science · doi:10.1126/science.283.5400.401 · Cited by 3,628
Drug Addiction, Dysregulation of Reward, and Allostasis
Koob, G. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00195-0 · Cited by 2,953
Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913
Determination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443 · cited 1×
“1 ), which led eventually to the pharmacological identification of cannabinoid-sensitive sites in the brai”
Background
Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,389
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196

Flagged first, then by citations

Show all 152 references

1 of the 152 references couldn’t be matched to a known paper.

Research works printed but not linked: 4

Rouyer, M. Sur les medicaments usuels des Egyptiens. Bull. Pharmacie 2, 25 (1810).
O'Shaugnessy, W. B. On the Cannabis indica or Indian hemp. Pharmacol. J. Trans. 2, 594 (1843).
Christison, R. in A Dispensatory, or Commentary on the Pharmacopoeias of Great Britain (and the United States) 971–974 (Lea and Blanchard, Philadelphia, 1848).
Adams, R. Marihuana. Harvey Lect. 37, 168 (1941).

Sorted by citations

Items 301–400 of 1,006

Cellular and System Biology of Memory: Timing, Molecules, and Beyond
Körte, M., & Schmitz, D. (2016) · Physiological Reviews · doi:10.1152/physrev.00010.2015 · Cited by 132
Distribution of type 1 cannabinoid receptor (CB1)‐immunoreactive axons in the mouse hypothalamus
Wittmann, G., Deli, L., Kalló, I., Hrabovszky, E., Watanabe, M., Liposits, Z., & Fekete, C. (2007) · The Journal of Comparative Neurology · doi:10.1002/cne.21383 · Cited by 125
Regulation of Gonadotropin-Releasing Hormone Secretion by Cannabinoids
Gammon, C. M., Freeman, G. M., Xie, W., Petersen, S. L., & Wetsel, W. C. (2005) · Endocrinology · doi:10.1210/en.2004-1672 · Cited by 126
Activating Parabrachial Cannabinoid CB 1 Receptors Selectively Stimulates Feeding of Palatable Foods in Rats
DiPatrizio, N. V., & Simansky, K. J. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1171-08.2008 · Cited by 129
Cannabinoid-induced changes in respiration of brain mitochondria
Fišar, Z., Singh, N., & Hroudová, J. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.09.002 · Cited by 127
Endocannabinoid signals in the control of emotion
Lutz, B. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.12.001 · Cited by 128
Cannabinoid Receptor Type 1 Protects Nigrostriatal Dopaminergic Neurons against MPTP Neurotoxicity by Inhibiting Microglial Activation
Chung, Y. C., Bok, E., Huh, S. H., Park, J., Yoon, S., Kim, S. R., Kim, Y., Maeng, S., Park, S. H., & Jin, B. K. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102435 · Cited by 123
CB1 receptors: emerging evidence for central and peripheral mechanisms that regulate energy balance, metabolism, and cardiovascular health
Cota, D. (2007) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.764 · Cited by 134
Modulation of neocortical interneurons: extrinsic influences and exercises in self-control
Bacci, A., Huguenard, J. R., & Prince, D. A. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.08.007 · Cited by 126
The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids
McAllister, S. D., Soroceanu, L., & Desprez, P. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9608-y · Cited by 144
Endocannabinoid 2-arachidonoylglycerol protects neurons against β-amyloid insults
Chen, X., Zhang, J., & Chen, C. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.01.024 · Cited by 123
Endocannabinoid Transport Revisited
Nicolussi, S., & Gertsch, J. (2015) · Vitamins and hormones · doi:10.1016/bs.vh.2014.12.011 · Cited by 130
Excess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agents
Clark, I. A., & Vissel, B. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0708-2 · Cited by 123
Exercise attenuates the clinical, synaptic and dendritic abnormalities of experimental autoimmune encephalomyelitis
Rossi, S., Furlan, R., Chiara, V. D., Musella, A., Giudice, T. L., Mataluni, G., Cavasinni, F., Cantarella, C., Bernardi, G., Muzio, L., et al. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.06.013 · Cited by 124
Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in mice
Steiner, M. A., Wanisch, K., Monory, K., Marsicano, G., Borroni, E., Bächli, H., Holsboer, F., Lutz, B., & Wotjak, C. T. (2007) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500466 · Cited by 130
The Endocannabinoid System and Extinction Learning
Lutz, B. (2007) · Molecular Neurobiology · doi:10.1007/s12035-007-8004-x · Cited by 124
Cell type–specific gating of perisomatic inhibition by cholecystokinin
Földy, C., Lee, S. Y., Szabadics, J., Neu, A. D., & Soltész, I. (2007) · Nature Neuroscience · doi:10.1038/nn1952 · Cited by 121
Retrograde Endocannabinoid Signaling Reduces GABAergic Synaptic Transmission to Gonadotropin-Releasing Hormone Neurons
Farkas, I., Kalló, I., Deli, L., Vida, B., Hrabovszky, E., Fekete, C., Moenter, S. M., Watanabe, M., & Liposits, Z. (2010) · Endocrinology · doi:10.1210/en.2010-0638 · Cited by 120
Enhancement of anandamide-mediated endocannabinoid signaling corrects autism-related social impairment
Wei, D., Dinh, D., Lee, D., Li, D., Anguren, A., Moreno-Sanz, G., Gall, C. M., & Piomelli, D. (2016) · Cannabis and Cannabinoid Research · doi:10.1089/can.2015.0008 · Cited by 122
Self-citation
Regional changes in type 1 cannabinoid receptor availability in Parkinson's disease in vivo
Laere, K. V., Casteels, C., Lunskens, S., Goffin, K. E., Grachev, I. D., Bormans, G. M., & Vandenberghe, W. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.02.009 · Cited by 120
Dendritic Calcium Spikes Are Tunable Triggers of Cannabinoid Release and Short-Term Synaptic Plasticity in Cerebellar Purkinje Neurons
Rancz, E. A., & Häusser, M. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.5284-05.2006 · Cited by 122
The potential therapeutic effects of THC on Alzheimer’s disease
Cao, C., Li, Y., Liu, H., Bai, G., Mayl, J., Lin, X., Sutherland, K., Nabar, N., & Cai, J. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140093 · Cited by 121
Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation
Hermanson, D. J., Gamble‐George, J., Marnett, L. J., & Patel, S. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.04.006 · Cited by 121
CB1 Agonist ACEA Protects Neurons and Reduces the Cognitive Impairment of AβPP/PS1 Mice
Aso, E., Palomer, E., Juvés, S., Maldonado, R. J., Muñoz, F. J., & Ferrer, I. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111862 · Cited by 122
The endocannabinoid system and gut–brain signalling
Storr, M., & Sharkey, K. A. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.08.008 · Cited by 120
L ocalization of the cannabinoid type‐1 receptor in subcellular astrocyte compartments of mutant mouse hippocampus
Gutiérrez‐Rodrίguez, A., Río, I. B., Puente, N., Gómez‐Urquijo, S., Fontaine, C. J., Huguet, J. E., Elezgarai, I., Ruehle, S., Lutz, B., Robin, L. M., et al. (2018) · Glia · doi:10.1002/glia.23314 · Cited by 127
Putative role of endocannabinoid signaling in the etiology of depression and actions of antidepressants
Gorzalka, B. B., & Hill, M. N. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.11.021 · Cited by 120
Current evidence of cannabinoid‐based analgesia obtained in preclinical and human experimental settings
Lötsch, J., Weyer-Menkhoff, I., & Tegeder, I. (2017) · European Journal of Pain · doi:10.1002/ejp.1148 · Cited by 123
Electrical Coupling among Irregular-Spiking GABAergic Interneurons Expressing Cannabinoid Receptors
Galarreta, M., Erdélyi, F., Szabó, G., & Hestrin, S. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.3027-04.2004 · Cited by 122
Wiring and firing neuronal networks: endocannabinoids take center stage
Harkany, T., Mackie, K., & Doherty, P. (2008) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2008.08.007 · Cited by 125
Thyroid Hormone Signaling and Homeostasis During Aging
Bowers, J., Terrien, J., Clerget-Froidevaux, M. S., Gothié, J. D., Rozing, M. P., Westendorp, R. G. J., van Heemst, D., & Demeneix, B. A. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1056 · Cited by 117
Opposing Roles for Cannabinoid Receptor Type-1 (CB1) and Transient Receptor Potential Vanilloid Type-1 Channel (TRPV1) on the Modulation of Panic-Like Responses in Rats
Casarotto, P. C., Terzian, A. L. B., Aguiar, D. C., Zangrossi, H., Guimarães, F. S., Wotjak, C. T., & Moreira, F. A. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.207 · Cited by 117
Cannabinoid CB1receptor‐interacting proteins: novel targets for central nervous system drug discovery?
Smith, T. H., Sim‐Selley, L. J., & Selley, D. E. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00777.x · Cited by 119
Endocannabinoids and neurodegenerative diseases
Micale, V., Mazzola, C., & Drago, F. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.09.008 · Cited by 119
Role of the endocannabinoid system in drug addiction
Manzanares, J., Cabañero, D., Puente, N., García‐Gutiérrez, M. S., Grandes, P., & Maldonado, R. J. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.09.013 · Cited by 118
5-HT1A receptors are involved in the anxiolytic effect of Δ9-tetrahydrocannabinol and AM 404, the anandamide transport inhibitor, in Sprague–Dawley rats
Braida, D., Limonta, V., Malabarba, L., Zani, A., & Sala, M. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.10.038 · Cited by 117
Neuropharmacology of the Endocannabinoid Signaling System-Molecular Mechanisms, Biological Actions and Synaptic Plasticity
Basavarajappa, B. S. (2007) · Current Neuropharmacology · doi:10.2174/157015907780866910 · Cited by 115
Multiple Mechanisms of Endocannabinoid Response Initiation in Hippocampus
Edwards, D. A., Kim, J., & Alger, B. E. (2005) · Journal of Neurophysiology · doi:10.1152/jn.00813.2005 · Cited by 113
Antiobesity effects of the novel in vivo neutral cannabinoid receptor antagonist 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole – LH 21
Pavón, F. J., Bilbao, A., Hernández‐Folgado, L., Cippitelli, A., Jagerovic, N., Abellán, G., Rodríguez-Franco, M. I., Serrano, A., Macías, M., de Heras, R. G., et al. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.03.029 · Cited by 115
Neurobiology of cannabinoid receptor signaling
Lutz, B. (2020) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2020.22.3/blutz · Cited by 119
Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat
Cippitelli, A., Cannella, N., Braconi, S., Duranti, A., Tontini, A., Bilbao, A., de Fonseca, F. R., Piomelli, D., & Ciccocioppo, R. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1104-0 · Cited by 114
Self-citation
Chronic Psychoemotional Stress Impairs Cannabinoid-Receptor-Mediated Control of GABA Transmission in the Striatum
Rossi, S., Chiara, V. D., Musella, A., Kusayanagi, H., Mataluni, G., Bernardi, G., Usiello, A., & Centonze, D. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.5346-07.2008 · Cited by 119
Neuromodulation of Hippocampal-Prefrontal Cortical Synaptic Plasticity and Functional Connectivity: Implications for Neuropsychiatric Disorders
Ruggiero, R. N., Rossignoli, M. T., Marques, D. B., de Sousa, B. M., Romcy-Pereira, R. N., Lopes-Aguiar, C., & Leite, J. P. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.732360 · Cited by 111
Medicinal Chemistry, Pharmacology, and Potential Therapeutic Benefits of Cannabinoid CB2Receptor Agonists
Tabrizi, M. A., Baraldi, P. G., Borea, P. A., & Varani, K. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00411 · Cited by 111
Retrograde Signalling by Endocannabinoids
Vaughan, C. W., & Christie, M. J. (2005) · Springer eBooks · doi:10.1007/3-540-26573-2_12 · Cited by 113
Endocannabinoids and Traumatic Brain Injury
Mechoulam, R., & Shohami, E. (2007) · Molecular Neurobiology · doi:10.1007/s12035-007-8008-6 · Cited by 111
Endocannabinoid Signaling in the Control of Social Behavior
Don, W., Allsop, S. A., Tye, K. M., & Piomelli, D. (2017) · Trends in Neurosciences · doi:10.1016/j.tins.2017.04.005 · Cited by 120
Self-citation
Anandamide Regulates Keratinocyte Differentiation by Inducing DNA Methylation in a CB1 Receptor-dependent Manner
Paradisi, A., Pasquariello, N., Barcaroli, D., & Maccarrone, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707964200 · Cited by 110
An endocannabinoid mechanism in relapse to drug seeking: A review of animal studies and clinical perspectives
Fattore, L., Spano, M. S., Deiana, S., Melis, V., Cossu, G., Fadda, P., & Fratta, W. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.05.003 · Cited by 110
Cocaine- and Amphetamine-Related Transcript Is Involved in the Orexigenic Effect of Endogenous Anandamide
Osei‐Hyiaman, D., DePetrillo, M. A., Harvey-White, J. D., Bannon, A. W., Cravatt, B. F., Kuhar, M. J., Mackie, K., Palkovits, M., & Kunos, G. (2005) · Neuroendocrinology · doi:10.1159/000087925 · Cited by 110
A brief history of cannabinoid and endocannabinoid pharmacology as inspired by the work of British scientists
Marzo, V. D. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.01.010 · Cited by 115
Group I Metabotropic Glutamate Receptors Inhibit GABA Release at Interneuron-Purkinje Cell Synapses through Endocannabinoid Production
Galante, M., & Diana, M. A. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0403-04.2004 · Cited by 110
The endocannabinoid system and the regulation of neural development: potential implications in psychiatric disorders
Galve‐Roperh, I., Palazuelos, J., Aguado, T., & Guzmán, M. (2009) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-009-0028-y · Cited by 113
Cannabinoids and the Brain
Köfalvi, A. (2007) · Springer eBooks · doi:10.1007/978-0-387-74349-3 · Cited by 110
Elevation of endogenous anandamide impairs LTP, learning, and memory through CB1 receptor signaling in mice
Basavarajappa, B. S., Nagre, N. N., Xie, S., & Subbanna, S. (2014) · Hippocampus · doi:10.1002/hipo.22272 · Cited by 107
URB602 Inhibits Monoacylglycerol Lipase and Selectively Blocks 2-Arachidonoylglycerol Degradation in Intact Brain Slices
King, A. R., Duranti, A., Tontini, A., Rivara, S., Rosengarth, A., Clapper, J. R., Astarita, G., Geaga, J. A., Luecke, H., Mor, M., et al. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.10.017 · Cited by 108
Self-citation
Inhibition of FAAH and activation of PPAR: New approaches to the treatment of cognitive dysfunction and drug addiction
Panlilio, L. V., Justinová, Z., & Goldberg, S. R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.003 · Cited by 106
Cannabidiol for neurodegenerative disorders: A comprehensive review
Bhunia, S., Kolishetti, N., Yndart, A., Vashist, A., & Nair, M. G. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.989717 · Cited by 121
Lipidomic analysis of endocannabinoid metabolism in biological samples
Astarita, G., & Piomelli, D. (2009) · Journal of Chromatography B · doi:10.1016/j.jchromb.2009.01.008 · Cited by 108
Self-citation
MECHANISMS IN ENDOCRINOLOGY: Endocannabinoids and metabolism: past, present and future
Simon, V., & Cota, D. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-1044 · Cited by 113
A quantitiative LC-MS/MS method for the measurement of arachidonic acid, prostanoids, endocannabinoids, N-acylethanolamines and steroids in human plasma
Gachet, M. S., Rhyn, P., Bosch, O. G., Quednow, B. B., & Gertsch, J. (2014) · Journal of Chromatography B · doi:10.1016/j.jchromb.2014.11.001 · Cited by 108
The endocannabinoid pathway in Huntington's disease: A comparison with other neurodegenerative diseases
Maccarrone, M., Battista, N., & Centonze, D. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.11.006 · Cited by 109
Nicotine and cannabinoids: parallels, contrasts and interactions
VIVEROS, M., MARCO, E., & FILE, S. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.08.002 · Cited by 106
Allosteric modulation of glycine receptors
Yévenes, G. E., & Zeilhofer, H. U. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01471.x · Cited by 111
Cannabinoids in Parkinson's Disease
Bassi, M. S., Sancesario, A., Morace, R., Centonze, D., & Iezzi, E. (2017) · Cannabis and Cannabinoid Research · doi:10.1089/can.2017.0002 · Cited by 114
Functional Redundancy Between Canonical Endocannabinoid Signaling Systems in the Modulation of Anxiety
Bedse, G., Hartley, N. D., Neale, E., Gaulden, A. D., Patrick, T. A., Kingsley, P. J., Uddin, M. J., Plath, N., Marnett, L. J., & Patel, S. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.03.002 · Cited by 108
The role of endocannabinoids in pain modulation
Zogopoulos, P., Vasileiou, I., Patsouris, E., & Theocharis, S. E. (2013) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12008 · Cited by 112
Cannabinoids produce neuroprotection by reducing intracellular calcium release from ryanodine-sensitive stores
Zhuang, S.-Y., Bridges, D., Grigorenko, E. V., McCloud, S., Boon, A., Hampson, R. E., & Deadwyler, S. A. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.01.005 · Cited by 106
Ethanol reverses the direction of long‐term synaptic plasticity in the dorsomedial striatum
Yin, H. H., Park, B. S., Adermark, L., & Lovinger, D. M. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05606.x · Cited by 106
Endocannabinoids mediate acute fear adaptation via glutamatergic neurons independently of corticotropin‐releasing hormone signaling
Kamprath, K., Plendl, W., Marsicano, G., Deussing, J. M., Wurst, W., Lutz, B., & Wotjak, C. T. (2008) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2008.00463.x · Cited by 104
Brain activity of anandamide: a rewarding bliss?
Scherma, M., Masia, P., Satta, V., Fratta, W., Fadda, P., & Tanda, G. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0075-x · Cited by 114
The effects of inhibition of fatty acid amide hydrolase (FAAH) by JNJ-42165279 in social anxiety disorder: a double-blind, randomized, placebo-controlled proof-of-concept study
Schmidt, M. E., Liebowitz, M. R., Stein, M. B., Grunfeld, J. A., Hove, I. V., Simmons, W. K., van der Ark, P. D., Palmer, J. A., Saad, Z. S., Pemberton, D. J., et al. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-00888-1 · Cited by 109
Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats
Seillier, A., Advani, T., Cassano, T., Hensler, J. G., & Giuffrida, A. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570999023x · Cited by 105
Bimodal Control of Fear-Coping Strategies by CB 1 Cannabinoid Receptors
Metna‐Laurent, M., Gómez, E. S., Verrier, D., Conforzi, M., Jégo, P., Lafenêtre, P., & Marsicano, G. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1054-12.2012 · Cited by 111
Enhanced Endocannabinoid Signaling Elevates Neuronal Excitability in Fragile X Syndrome
Zhang, L., & Alger, B. E. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0795-10.2010 · Cited by 104
Endocannabinoids and Retrograde Modulation of Synaptic Transmission
Ohno‐Shosaku, T., Tanimura, A., Hashimotodani, Y., & Kano, M. (2011) · The Neuroscientist · doi:10.1177/1073858410397377 · Cited by 104
Inhibition of fatty-acid amide hydrolase enhances cannabinoid stress-induced analgesia: Sites of action in the dorsolateral periaqueductal gray and rostral ventromedial medulla
Suplita, R. L., Farthing, J. N., Gutierrez, T., & Hohmann, A. G. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.07.007 · Cited by 104
The Endogenous Cannabinoid Anandamide and Its Synthetic Analog R(+)-Methanandamide Are Intravenously Self-Administered by Squirrel Monkeys
Justinová, Z. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.0951-05.2005 · Cited by 104
The Endogenous Cannabinoid Anandamide Produces δ-9-Tetrahydrocannabinol-Like Discriminative and Neurochemical Effects That Are Enhanced by Inhibition of Fatty Acid Amide Hydrolase but Not by Inhibition of Anandamide Transport
Solinas, M., Tanda, G., Justinová, Z., Wertheim, C. E., Yaşar, S., Piomelli, D., Vadivel, S. K., Makriyannis, A., & Goldberg, S. R. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.114124 · Cited by 107
Self-citation
Correlated species differences in the effects of cannabinoid ligands on anxiety and on GABAergic and glutamatergic synaptic transmission
Haller, J., Mátyás, F., Soproni, K., Varga, B., Barsy, B., Németh, B., Mikics, É., Freund, T. F., & Hájos, N. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05476.x · Cited by 103
Functional characterization of putative cholesterol binding sequence (CRAC) in human type‐1 cannabinoid receptor
Oddi, S., Dainese, E., Fezza, F., Lanuti, M., Barcaroli, D., Laurenzi, V. D., Centonze, D., & Maccarrone, M. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07041.x · Cited by 103
CB1 receptor deficiency decreases wheel-running activity: Consequences on emotional behaviours and hippocampal neurogenesis
Dubreucq, S., Koehl, M., Abrous, D. N., Marsicano, G., & Chaouloff, F. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.01.017 · Cited by 103
Cannabinoid signaling in health and disease
Lu, Y., & Anderson, H. D. (2017) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2016-0346 · Cited by 105
The Role of Endocannabinoid Signaling in the Molecular Mechanisms of Neurodegeneration in Alzheimer's Disease
Bedse, G., Romano, A., Lavecchia, A. M., Cassano, T., & Gaetani, S. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141635 · Cited by 109
Retrograde endocannabinoid signaling at striatal synapses requires a regulated postsynaptic release step
Adermark, L., & Lovinger, D. (2007) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.0706873104 · Cited by 103
Anandamide–CB1Receptor Signaling Contributes to Postnatal Ethanol-Induced Neonatal Neurodegeneration, Adult Synaptic, and Memory Deficits
Subbanna, S., Shivakumar, M., Psychoyos, D., Xie, S., & Basavarajappa, B. S. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3786-12.2013 · Cited by 100
The CB2 cannabinoid receptor signals apoptosis via ceramide-dependent activation of the mitochondrial intrinsic pathway
Herrera, B. M., Carracedo, A., Diez-Zaera, M., del Pulgar, T. G., Guzmán, M., & Velasco, G. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.03.009 · Cited by 104
Anandamide as an intracellular messenger regulating ion channel activity
van der Stelt, M., & Marzo, V. D. (2004) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2004.09.007 · Cited by 102
Cannabinoids and the skeleton: From marijuana to reversal of bone loss
Bab, I., Zimmer, A. D., & Melamed, E. (2009) · Annals of Medicine · doi:10.1080/07853890903121025 · Cited by 103
Protective activation of the endocannabinoid system during ischemia in dopamine neurons
Melis, M., Pillolla, G., Bisogno, T., Minassi, A., Petrosino, S., Perra, S., Muntoni, A. L., Lutz, B., Gessa, G. L., & Marsicano, G. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.04.010 · Cited by 101
Dissecting the cannabinergic control of behavior: The where matters
Busquets-García, A., Desprez, T., Metna‐Laurent, M., Bellocchio, L., Marsicano, G., & Gómez, E. S. (2015) · BioEssays · doi:10.1002/bies.201500046 · Cited by 111
Distribution of cannabinoid receptor 1 in the CNS of zebrafish
Lam, C. S., Rastegar, S., & Strähle, U. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.10.069 · Cited by 99
Fatty Acid Amide Hydrolase: A Gate-Keeper of the Endocannabinoid System
Fezza, F., De Simone, C., Amadio, D., & Maccarrone, M. (2008) · Subcellular Biochemistry · doi:10.1007/978-1-4020-8831-5_4 · Cited by 99
A peripherally restricted cannabinoid receptor agonist produces robust anti-nociceptive effects in rodent models of inflammatory and neuropathic pain
Yu, X. H., Cao, C. Q., Martino, G., Puma, C., Morinville, A., St-Onge, S., Lessard, É., Perkins, M., & Laird, J. M. A. (2010) · Pain · doi:10.1016/j.pain.2010.07.019 · Cited by 102
Astroglial type-1 cannabinoid receptor (CB1): A new player in the tripartite synapse
da Cruz, J. F. O., Robin, L. M., Drago, F., Marsicano, G., & Metna‐Laurent, M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.05.002 · Cited by 99
Ultra performance liquid chromatography tandem mass spectrometry method for the measurement of anandamide in human plasma
Lam, P. M. W., Marczylo, T. H., El-Talatini, M. R., Finney, M., Nallendran, V., Taylor, A. H., & Konje, J. C. (2008) · Analytical Biochemistry · doi:10.1016/j.ab.2008.05.033 · Cited by 98
Lipid Signaling and Synaptic Plasticity
Sang, N., & Chen, C. (2006) · The Neuroscientist · doi:10.1177/1073858406290794 · Cited by 98
Intracellular Cannabinoid Type 1 (CB1) Receptors Are Activated by Anandamide
Brailoiu, G. C., Oprea, T. I., Zhao, P., Abood, M. E., & Brailoiu, E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.217463 · Cited by 99
Systemic Administration of Oleoylethanolamide Protects from Neuroinflammation and Anhedonia Induced by LPS in Rats
Sayd, A., Antón, M., Alén, F., Caso, J. R., Pavon, J., Leza, J. C., de Fonseca, F. R., García‐Bueno, B., & Orío, L. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu111 · Cited by 102
Signaling pathways to and from the hypophysial pars tuberalis, an important center for the control of seasonal rhythms
Korf, H. (2017) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2017.05.011 · Cited by 103

Authors: Piomelli, D.
Affiliations: University of California, Irvine (US)
Corresponding author: Piomelli, Daniele
ORCID: Piomelli, Daniele
Venue: Nature Reviews Neuroscience
Publisher: Springer Science and Business Media LLC
Published: 2003-11
Volume: 4
Issue: 11
Pages: 873-884
ISSN: 1471-003X (ISSN-L)
1471-0048
DOI: 10.1038/nrn1247
OpenAlex: W2080649553
Cited by: 1,957
References: 152
Citations by year: 2026: 39 · 2025: 42 · 2024: 43 · 2023: 50 · 2022: 76 · 2021: 77 · 2020: 81 · 2019: 71 · 2018: 67 · 2017: 79 · 2016: 81 · 2015: 100 · 2014: 100 · 2013: 95 · 2012: 108
FWCI: 9.35
Type: journal article
Language: en
Open access: green
escholarship.org
Licence: cc-by
www.springer.com/tdm (tdm)
Locations: Nature reviews. Neuroscience (publishedVersion)
PubMed (publishedVersion)
eScholarship (California Digital Library) (submittedVersion, cc-by)
Funders: National Alliance for Research on Schizophrenia and Depression
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Keywords: endocannabinoids, endocannabinoid signaling, CB1 receptor, delta-9-tetrahydrocannabinol, cannabinoid receptors, neurotransmitter release, ion channel modulation, synaptic plasticity, axon terminals
MeSH terms: Animals, Cannabis, gamma-Aminobutyric Acid, Hallucinogens, Humans, Synaptic Transmission, Dronabinol, Signal Transduction, Neurotransmitter Agents, Glutamic Acid, Receptor, Cannabinoid, CB1, Cannabinoid Receptor Modulators, Endocannabinoids

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The molecular logic of endocannabinoid signalling

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks